RVAC Medicines
MRNA platform company engaged in the research and development of innovative products such as vaccines for diseases.
Employees
Enterprise value
$560—840m
| Date | Investors | Amount | Round |
|---|---|---|---|
* | $140m | Series B | |
| Total Funding | 000k | ||
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads